Your activity: 2 p.v.

Society guideline links: Thrombotic diseases in infants and children

Society guideline links: Thrombotic diseases in infants and children

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Anticoagulation".)

International

International Society on Thrombosis and Haemostasis (ISTH): Guidance for the identification of at-risk patients and prevention of venous thromboembolism in pediatric cancer (2017)

ISTH: Recommendations for the assessment of non-extremity venous thromboembolism outcomes (2014)

Canada

Thrombosis Canada (TC): Clinical guides

Canadian Association of Gastroenterology (CAG): Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease (2014)

United States

Choosing Wisely: Don't order a factor V Leiden (FVL) mutation assay as the initial test to identify a congenital cause for a thrombotic event. First, order a phenotypic activated protein C resistance (APCR) ratio assay (2020)

Choosing Wisely: Don't order thrombophilia testing on children with venous access (ie, peripheral or central) associated thrombosis in the absence of a positive family history (2019)

American Society of Hematology (ASH): Guidelines for management of venous thromboembolism – Treatment of pediatric venous thromboembolism (2018)

Choosing Wisely: Don't image for suspected pulmonary embolism (PE) without moderate or high pre-test probability of PE (2012, updated 2017)

Choosing Wisely: Don't place, or leave in place, peripherally inserted central catheters for patient or provider convenience (2012, revised 2017)

Eastern Association for the Surgery of Trauma (EAST) and the Pediatric Trauma Society (PTS): A practice management guideline on prophylaxis against venous thromboembolism in pediatric trauma (2017)

Choosing Wisely: Don't order MTHFR genetic testing for the risk assessment of hereditary thrombophilia (2015, updated 2016)

Pediatric Cardiac Intensive Care Society (PCICS): Consensus statement on pharmacotherapies in cardiac critical care anticoagulation and thrombolysis, 2014 (published 2016)

AHA: A scientific statement on the postthrombotic syndrome – Evidence-based prevention, diagnosis, and treatment strategies (2014)

Choosing Wisely: Don't recommend bed rest following diagnosis of acute deep vein thrombosis (DVT) after the initiation of anti-coagulation therapy, unless significant medical concerns are present (2014)

Choosing Wisely: Don't test or treat for suspected heparin-induced thrombocytopenia (HIT) in patients with a low pre-test probability of HIT (2014)

Choosing Wisely: Don't treat with an anticoagulant for more than three months in a patient with a first venous thromboembolism (VTE) occurring in the setting of a major transient risk factor (2014)

AHA: A scientific statement for prevention and treatment of thrombosis in pediatric and congenital heart disease (2013)

Choosing Wisely: Don't do work up for clotting disorder (order hypercoagulable testing) for patients who develop first episode of deep vein thrombosis (DVT) in the setting of a known cause (2013)

American College of Chest Physicians (CHEST): Evidence-based clinical practice guidelines on antithrombotic therapy and prevention of thrombosis, 9th edition – Antithrombotic therapy in neonates and children (2012)

Europe

The Single Hub and Access point for paediatric Rheumatology in Europe (SHARE): European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome (2017)

United Kingdom

British Society for Haematology (BSH): Guideline for management of thrombotic and haemostatic issues in paediatric malignancy (2018)

Scottish Intercollegiate Guidelines Network (SIGN): A national clinical guideline on antithrombotics – Indications and management (2012)

British Committee for Standards in Haematology (BCSH) and BSH: Guideline on the investigation, management, and prevention of venous thrombosis in children (2011)

Australia-New Zealand

Choosing Wisely Australia: Do not extend anticoagulation beyond 3 months for a patient with a non-extensive, index venous thromboembolic event (VTE), which occurred in the setting of a major, transient risk factor (2015)

Japan

[In Japanese] Japanese Circulation Society (JCS): Guidelines for diagnosis, treatment and prevention of pulmonary thromboembolism and deep vein thrombosis (2017, updated 2020)

Topic 117261 Version 10.0